References
- Gil Navarro N, Garcia Grau E, Pina Pérez S, et al. Ovarian torsion and spontaneous ovarian hyperstimulation syndrome in a twin pregnancy: a case report. Int J Surg Case Rep. 2017;34:66–68.
- Kanza RE, Gagnon S, Villeneuve H, et al. Spontaneous ovarian hyperstimulation syndrome and pituitary hyperplasia mimicking macroadenoma associated with primary hypothyroidism. Wjr. 2013;5:20–24.
- Sridev S, Barathan S. Case report on spontaneous ovarian hyperstimulation syndrome following natural conception associated with primary hypothyroidism. J Hum Reprod Sci. 2013;6:158–161.
- Mittal K, Koticha R, Dey AK, et al. Radiological illustration of spontaneous ovarian hyperstimulation syndrome. Pol J Radiol. 2015;28:217–227.
- Montanelli L, Delbaere A, Di Carlo C, et al. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 2004;89:1255–1258.
- Di Carlo C, Savoia F, Fabozzi A, et al. A case of ovarian torsionin a patient carrier of a FSH receptor gene mutation previously affected by spontaneous ovarian hyperstimulation syndrome. Gynecol. Endocrinol. 2015;31:105–108.
- Munshi S, Patel A, Banker M, et al. Laparoscopic detorsion for bilateral ovarian torsion in a singleton pregnancy with spontaneous ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2014;7:66–68.
- Lussiana C, Guani B, Restagno G, et al. Ovarian hyperstimulation syndrome after spontaneous conception. Gynecol Endocrinol. 2009;25:455–459.
- Ahmed Kamel RM. Spontaneous ovarian hyperstimulation syndrome in a naturally conceived singleton pregnancy. Fertil Steril. 2010;94:5.
- Şafak H. Servet Gençdal2, Melahat Atasever3, Emre Ekmekçi4, Murat Bakacak5, Sefa Kelekçi4 Evaluation of polycystic ovary syndrome patients treated for OHSS. J Infertility Rep Biol. 2015;3:179–183.
- Papaleo E, Doldi N, De S, et al. Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome. Hum Reprod. 2001;16:2263–2266.
- Alvarez C, Alonso-Muriel I, Garcia G, et al. Implantiation is apparently unaffected by the dopamine agonist cobergoline when administerred to prevent ovarian hyperstimulation syndrome in women undergoing assited reproduction treatment: a pilot study. Hum Reprod. 2007;22:3210–3214.
- Alvarez C, Marti b. L, Novella- Maestre E, et al. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab. 2007;92:2931–2937.
- Baumgarten M, Polanski L, Campbell B, et al. Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis. Hum Fertil (Camb). 2013;16:168–174.